1.Dubey, JP (2010) Toxoplasmosis of Animals and Humans. Boca Raton, Florida: CRC Press, pp. 1–313.
2.Montoya, JG and Liesenfeld, O. (2004) Toxoplasmosis. Lancet 363, 1965–1976.
3.Cong, W et al. (2015) Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Letters 359, 307–313.
4.Wang, L et al. (2015) Seroprevalence and genetic characterization of Toxoplasma gondii in cancer patients in Anhui province, Eastern China. Parasites & Vectors 8, 162.
5.Zhou, P et al. (2011) Toxoplasma gondii infection in humans in China. Parasites & Vectors 4, 165.
6.Ferreira, MS and Borges, AS (2002) Some aspects of protozoan infections in immunocompromised patients: a review. Memórias do Instituto Oswaldo Cruz 97, 443–457.
7.Majidiani, H et al. (2016) Is chronic toxoplasmosis a risk factor for diabetes mellitus? A systematic review and meta-analysis of case-control studies. The Brazilian Journal of Infectious Diseases 20, 605–609.
8.Sutterland, AL et al. (2015) Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatrica Scandinavica 132, 161–179.
9.Yazar, S et al. (2004) Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. Journal of Medical Microbiology 53, 1183–1186.
10.Thomas, F et al. (2012) Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biology Letters 8, 101–103.
11.Jemal, A et al. (2011) Global cancer statistics. A Cancer Journal for Clinicians 61, 69–90.
12.Cannon, G et al. (2012) Prevention of cancer and non-communicable diseases. Asian Pacific Journal of Cancer Prevention: APJCP 13, 3–11.
13.Dubey, JP (2009) History of the discovery of the life cycle of Toxoplasma gondii. International Journal for Parasitology 39, 877–882.
14.Jiang, C et al. (2015) The seroprevalence of Toxoplasma gondii in Chinese population with cancer: a systematic review and meta-analysis. Medicine (Baltimore) 94, e2274.
15.Imam, A et al. (2017) Serologic evidence of Toxoplasma gondii infection among cancer patients. A prospective study from Qassim region, Saudi Arabia. Saudi Medical Journal 38, 319–321.
16.Chintakuntlawar, A et al. (2015) Toxoplasmosis in patients with hematologic malignancies. Leukemia & Lymphoma 56, 536–538.
17.Fallahi, Sh et al. (2014) Comparison of the RE and B1 gene for detection of Toxoplasma gondii infection in children with cancer. Parasitology International 63, 37–41.
18.Fox, BA et al. (2017) Cancer therapy in a microbial bottle: uncorking the novel biology of the protozoan Toxoplasma gondii. PLoS Pathogens 13, e1006523.
19.Huang, Y et al. (2016) Is Toxoplasma gondii infection a risk factor for leukemia? An evidence-based meta-analysis. Medical Science Monitor 22, 1547–1552.
20.Jung, BK et al. (2016) High Toxoplasma gondii Seropositivity among brain tumor patients in Korea. Korean Journal for Parasitology 54, 201–204.
21.Lun, ZR et al. (2015) Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii. Proceedings of the National Academy of Sciences of the United States of America 112, 8835–8842.
22.Messinger, CJ et al. (2017) Seroprevalence of Bartonella species, Coxiella burnetii and Toxoplasma gondii among patients with hematological malignancies: a pilot study in Romania. Zoonoses and Public Health 64, 485–490.
23.Saki, J et al. (2017) Seroprevalence and molecular evaluation of toxoplasmosis in children with cancer in Khuzestan province, Southwest of Iran. Journal of Parasitic Diseases 41, 947–951.
24.Seyedeh, MS et al. (2015) Low titer of antibody against Toxoplasma gondii may be related to resistant to cancer. Journal of Cancer Research and Therapeutics 11, 305–307.
25.Tian, AL et al. (2017) Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China. Epidemiology and Infection 145, 2296–2302.
26.Wang, ZD et al. (2017) Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Frontiers in Microbiology 8, 389.
27.Ferlay, J et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136, E359–E386.
28.Warnakulasuriya, S (2009) Causes of oral cancer – an appraisal of controversies. British Dental Journal 207, 471–475.
29.Dhanuthai, K et al. (2018) Oral cancer: a multicenter study. Medicina Oral, Patología Oral y Cirugía Bucal 23, e23–e29.
30.Chaturvedi, AK et al. (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. Journal of Clinical Oncology 26, 612–619.
31.D'Souza, G et al. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. The New England Journal of Medicine 356, 1944–1956.
32.Harker, KS et al. (2015) Toxoplasma gondii dissemination: a parasite's journey through the infected host. Parasite Immunology 37, 141–149.
33.Unno, A et al. (2008) Dissemination of extracellular and intracellular Toxoplasma gondii tachyzoites in the blood flow. Parasitology International 57, 515–518.
34.Alvarado-Esquivel, C et al. (2018) Association between Toxoplasma gondii infection and history of blood transfusion: a case-control seroprevalence study. The Journal of International Medical Research 46, 1626–1633.
35.Dabritz, HA and Conrad, PA (2010) Cats and Toxoplasma: implications for public health. Zoonoses and Public Health 57, 34–52.
36.Du, F et al. (2012) Survey on the contamination of Toxoplasma gondii oocysts in the soil of public parks of Wuhan, China. Veterinary Parasitology 184, 141–146.
37.Jones, JL et al. (2009) Risk factors for Toxoplasma gondii infection in the United States. Clinical Infectious Diseases 49, 878–884.
38.Dubey, JP (2004) Toxoplasmosis – a waterborne zoonosis. Veterinary Parasitology 126, 57–72.
39.Lindsay, DS et al. (2003) Sporulation and survival of Toxoplasma gondii oocysts in sea water. The Journal of Eukaryotic Microbiology 50, S687–S688.
40.Bigot-Clivot, A et al. (2016) Bioaccumulation of Toxoplasma and Cryptosporidium by the freshwater crustacean Gammarus fossarum: involvement in biomonitoring surveys and trophic transfer. Ecotoxicology and Environmental Safety 133, 188–194.
41.Massie, GN et al. (2010) Uptake and transmission of Toxoplasma gondii oocysts by migratory, filter-feeding fish. Veterinary Parasitology 169, 296–303.
42.Putignani, L et al. (2011) Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG). Experimental Parasitology 127, 409–417.
43.Schott, KC et al. (2016) Concentration and retention of Toxoplasma gondii surrogates from seawater by red abalone (Haliotis rufescens). Parasitology 143, 1703–1712.
44.Cong, W et al. (2017) First detection and genetic characterization of Toxoplasma gondii in market-sold oysters in China. Infection Genetics and Evolution 54, 276–278.